Hydroxychloroquine Pill + Azithromycin Pill for respiratory distress syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Feb 2021: Trial started, NCT04954040
  2. 8 Jul 2021: Trial registered, NCT04954040

The trials

NCT04954040: Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19

State
State not given
Phase
Phase 2
People
132 planned
Started
10 Feb 2021
Primary completion
Oct 2021
Arms
Hydroxychloroquine + Azithromycin
Results
None posted
  1. 10 Feb 2021: Trial started
  2. 8 Jul 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.